Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling

T Kolben, U Jeschke, T Reimer, N Karsten… - Journal of cancer …, 2018 - Springer
Abstract Purpose The Fas-antigen is a cell surface receptor that transduces apoptotic
signals into cells. The purpose of this study was to evaluate FasL expression in breast …

Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling

T Kolben, U Jeschke, T Reimer… - Journal of Cancer …, 2018 - epub.ub.uni-muenchen.de
Purpose The Fas-antigen is a cell surface receptor that transduces apoptotic signals into
cells. The purpose of this study was to evaluate FasL expression in breast cancer and to …

Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling.

T Kolben, U Jeschke, T Reimer, N Karsten… - Journal of Cancer …, 2017 - europepmc.org
Purpose The Fas-antigen is a cell surface receptor that transduces apoptotic signals into
cells. The purpose of this study was to evaluate FasL expression in breast cancer and to …

Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling

T Kolben, U Jeschke, T Reimer… - Journal of cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
Purpose The Fas-antigen is a cell surface receptor that transduces apoptotic signals into
cells. The purpose of this study was to evaluate FasL expression in breast cancer and to …

Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling.

T Kolben, U Jeschke, T Reimer… - Journal of Cancer …, 2018 - search.ebscohost.com
Abstract Purpose: The Fas-antigen is a cell surface receptor that transduces apoptotic
signals into cells. The purpose of this study was to evaluate FasL expression in breast …

Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling

T Kolben, U Jeschke, T Reimer… - Journal of Cancer …, 2018 - search.proquest.com
Purpose The Fas-antigen is a cell surface receptor that transduces apoptotic signals into
cells. The purpose of this study was to evaluate FasL expression in breast cancer and to …